Diane Retallack, PhDPresident & COO at Primrose BioSpeaker
Profile
Diane was a founding member of the team that established the Pfenex Expression Technology® platform, overseeing strain engineering, HTP screening, and upstream development. With over 25 years of experience in molecular biology, protein expression and executive management, she has contributed to multiple therapeutic programs from product conception through commercialization. Diane completed her doctorate at the University of Michigan and post-doctoral work at the University of Wisconsin-Madison.
Agenda Sessions
Streamlined Antibody and Therapeutic Development Using The Pfenex Expression Technology® Platform
, 12:05pmView Session